Celularity Inc (CELU) Insider Trading Disclosures
Celularity Inc (CELU) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CELU
CIK: 1752828
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EisnerAmper LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerMarc Fogarty
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-29 | 2026-09-29 | 8-K | 0001493152-26-044917 | View SEC Doc Filr Page |
| 10-Q | 2026-09-29 | 2026-03-31 | 10-Q | 0001493152-26-044892 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-28 | — | SCHEDULE 13D/A Filing | 0001104659-26-111279 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-18 | 8-K | 0001493152-26-044421 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | OWNERSHIP DOCUMENT | 0001104659-26-111028 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | OWNERSHIP DOCUMENT | 0001104659-26-111027 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | OWNERSHIP DOCUMENT | 0001104659-26-111026 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-11 | 8-K | 0001493152-26-042495 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-14 | 2026-06-30 | NT 10-Q | 0001493152-26-038318 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-05 | 8-K | 0001493152-26-036648 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-23 | 8-K | 0001493152-26-035193 | View SEC Doc Filr Page |
| 25-NSE | 2026-07-22 | — | 25-NSE Filing | 0001354457-26-000719 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-26 | 8-K | 0001493152-26-031216 | View SEC Doc Filr Page |
| 8-K | 2026-06-25 | 2026-06-19 | 8-K | 0001493152-26-030199 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-19 | OWNERSHIP DOCUMENT | 0001104659-26-076683 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-19 | OWNERSHIP DOCUMENT | 0001104659-26-076682 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-19 | OWNERSHIP DOCUMENT | 0001104659-26-076681 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-23 | — | SCHEDULE 13D/A Filing | 0001104659-26-076580 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-09 | 8-K | 0001493152-26-028519 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-05-29 | 8-K | 0001493152-26-027132 | View SEC Doc Filr Page |
| 8-K | 2026-05-28 | 2026-05-21 | 8-K | 0001493152-26-025646 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NT 10-Q | 0001493152-26-023840 | View SEC Doc Filr Page |
| 10-K | 2026-04-30 | 2025-12-31 | 10-K | 0001493152-26-020424 | View SEC Doc Filr Page |
| 3 | 2026-04-24 | 2026-04-20 | OWNERSHIP DOCUMENT | 0001104659-26-048765 | View SEC Doc Filr Page |
| 3 | 2026-04-24 | 2026-04-20 | OWNERSHIP DOCUMENT | 0001104659-26-048764 | View SEC Doc Filr Page |